{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:31:01Z","timestamp":1790116261339,"version":"4.0.1"},"reference-count":25,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/bjophthalmol-2017-310220","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:10:49Z","timestamp":1492042249000},"page":"1699-1703","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Intravitreal dexamethasone implant in radiation-induced macular oedema"],"prefix":"10.1136","volume":"101","author":[{"given":"Luisa","family":"Frizziero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Parrozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Trainiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Miglionico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Pulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Midena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2017-310220-1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICU.0b013e3283386687","article-title":"Classification and treatment of radiation maculopathy","volume":"21","author":"Horgan","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0161-6420(96)30450-8","article-title":"The effect of external eye irradiation on choroidal circulation","volume":"103","author":"Midena","year":"1996","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310220-3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/00006982-200510000-00009","article-title":"Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma","volume":"25","author":"Shields","year":"2005","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310220-4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2012.06.026","article-title":"Intravitreal triamcinolone versus Intravitreal Bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma","volume":"155","author":"Parrozzani","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-5","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1097\/IAE.0000000000000986","article-title":"Hyperreflective intraretinal spots in radiation macular edema on spectral domain optical coherence tomography","volume":"36","author":"Frizziero","year":"2016","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310220-6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5301\/ejo.5000670","article-title":"Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study","volume":"26","author":"Finger","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/0284186X.2010.500299","article-title":"Current treatments for radiation retinopathy","volume":"50","author":"Giuliari","year":"2011","journal-title":"Acta Oncol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/IAE.0b013e31806e6042","article-title":"Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma","volume":"27","author":"Mason","year":"2007","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310220-9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1740774511419684","article-title":"Collaborative ocular melanoma study randomized trial of I-125 brachytherapy","volume":"8","author":"Hawkins","year":"2011","journal-title":"Clin Trials"},{"key":"key-10.1136\/bjophthalmol-2017-310220-10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(98)98023-X","article-title":"The efficacy of focal laser therapy in radiation-induced macular edema","volume":"105","author":"Hykin","year":"1998","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310220-11","first-page":"1739","article-title":"Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using Intravitreal Bevacizumab maintains functional visual acuity","volume":"6","author":"Shah","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.5301\/ejo.5000333","article-title":"High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy","volume":"23","author":"Finger","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-13","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/IAE.0000000000000537","article-title":"Intravitreal dexamethasone implant for radiation maculopathy secondary to plaque brachytherapy in choroidal melanoma","volume":"35","author":"Caminal","year":"2015","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310220-14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/IAE.0b013e3181706302","article-title":"Treatment of radiation maculopathy with intravitreal injection of Bevacizumab (Avastin)","volume":"28","author":"Gupta","year":"2008","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310220-15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ophtha.2013.08.039","article-title":"Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma","volume":"121","author":"Shah","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310220-16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajo.2016.04.024","article-title":"Antiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanoma","volume":"168","author":"Seibel","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00417-006-0516-y","article-title":"M\u00fcller cells as players in retinal degeneration and edema","volume":"245","author":"Reichenbach","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat Cell Biol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000337144","article-title":"Radiation macular edema after Ru-106 plaque brachytherapy for choroidal melanoma resolved by an intravitreal dexamethasone 0.7-mg implant","volume":"3","author":"Russo","year":"2012","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ajo.2009.09.007","article-title":"Serous retinal detachment associated with retinal vein occlusion","volume":"149","author":"Tsujikawa","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12325-011-0019-z","article-title":"The dexamethasone drug delivery system: indications and evidence","volume":"28","author":"London","year":"2011","journal-title":"Adv Ther"},{"key":"key-10.1136\/bjophthalmol-2017-310220-22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ICB.0000000000000032","article-title":"Treatment of recalcitrant radiation maculopathy using intravitreal dexamethasone (Ozurdex) implant","volume":"8","author":"Bui","year":"2014","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.1136\/bjophthalmol-2017-310220-23","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1111\/aos.12424","article-title":"Ozurdex(\u00ae) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab","volume":"92","author":"Tarmann","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310220-24","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/IAE.0b013e31829234fa","article-title":"Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma","volume":"33","author":"Baillif","year":"2013","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310220-25","first-page":"1877","article-title":"Combination therapy with triamcinolone acetonide and Bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma","volume":"7","author":"Shah","year":"2013","journal-title":"Clin Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:54:59Z","timestamp":1601110499000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310220"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310220","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}